Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO)

CUSIP: 02157Q109

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
31,755,000
Total 13F shares
16,755,091
Share change
-526,457
Total reported value
$67,358,617
Price per share
$4.02
Number of holders
74
Value change
-$1,672,076
Number of buys
26
Number of sells
35

Security key

02157Q109

Report period

Q3 2025

Institutions

74

Top holders

10

Top shareholders of ANRO - Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13D/G 13F
Company
4.7%
1,265,546
$2,885,445 $0 31 Dec 2024
BlackRock, Inc.
13F 13D/G
Company
2.1%
from 13D/G
561,848
$1,236,065 30 Jun 2025
Alpha Wave Global, LP
13F 3/4/5
Company · 10%+ Owner
12%
3,707,757
$8,157,065 30 Jun 2025
ARMISTICE CAPITAL, LLC
13F
Company
5.1%
1,624,000
$3,572,800 30 Jun 2025
13F
Point72 Asset Management, L.P.
13F
Company
4.2%
1,329,755
$2,925,461 30 Jun 2025
13F
FRANKLIN RESOURCES INC
13F
Company
3.7%
1,162,608
$2,557,738 30 Jun 2025
13F
VANGUARD GROUP INC
13F
Company
3.4%
1,084,705
$2,386,351 30 Jun 2025
13F
Vestal Point Capital, LP
13F
Company
3%
950,000
$2,090,000 30 Jun 2025
13F
MARSHALL WACE, LLP
13F
Company
3%
937,407
$2,062,295 30 Jun 2025
13F
72 Investment Holdings, LLC
13F
Company
2.1%
667,778
$1,469,112 30 Jun 2025
13F
ALKEON CAPITAL MANAGEMENT LLC
13F
Company
1.5%
477,101
$1,049,622 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
1.5%
463,344
$1,019,357 30 Jun 2025
13F
UBS Group AG
13F
Company
1.3%
428,216
$942,076 30 Jun 2025
13F
Integral Health Asset Management, LLC
13F
Company
1.3%
400,000
$880,000 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.95%
302,862
$666,296 30 Jun 2025
13F
AWM Investment Company, Inc.
13F
Company
0.88%
280,483
$617,063 30 Jun 2025
13F
Peapod Lane Capital LLC
13F
Company
0.88%
278,857
$613,485 30 Jun 2025
13F
ORBIMED ADVISORS LLC
13F
Company
0.79%
250,000
$550,000 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.72%
229,721
$505,641 30 Jun 2025
13F
Almitas Capital LLC
13F
Company
0.61%
195,145
$429,319 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.52%
166,087
$365,391 30 Jun 2025
13F
STIFEL FINANCIAL CORP
13F
Company
0.4%
126,853
$279,077 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.36%
115,263
$253,579 30 Jun 2025
13F
Ikarian Capital, LLC
13F
Company
0.35%
110,000
$242,001 30 Jun 2025
13F
JANE STREET GROUP, LLC
13F
Company
0.34%
109,020
$239,844 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.33%
104,734
$230,415 30 Jun 2025
13F
Laird Norton Wetherby Wealth Management, LLC
13F
Company
0.27%
84,162
$185,157 30 Jun 2025
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.26%
82,200
$180,840 30 Jun 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.24%
76,512
$168,326 30 Jun 2025
13F
Squarepoint Ops LLC
13F
Company
0.21%
67,948
$149,486 30 Jun 2025
13F
SCS Capital Management LLC
13F
Company
0.21%
66,777
$146,909 30 Jun 2025
13F
IEQ CAPITAL, LLC
13F
Company
0.21%
65,189
$143,416 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.2%
64,630
$142,185 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.19%
61,063
$134,339 30 Jun 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.19%
59,428
$131,000 30 Jun 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.17%
54,100
$119,020 30 Jun 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.14%
44,735
$98,417 30 Jun 2025
13F
CANTOR FITZGERALD, L. P.
13F
Individual
0.13%
40,000
$88,000 30 Jun 2025
13F
Y-Intercept (Hong Kong) Ltd
13F
Company
0.12%
38,597
$84,913 30 Jun 2025
13F
Allianz Asset Management GmbH
13F
Company
0.12%
37,000
$81,400 30 Jun 2025
13F
Quantinno Capital Management LP
13F
Company
0.11%
35,579
$78,274 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.11%
34,700
$76,340 30 Jun 2025
13F
CITIZENS FINANCIAL GROUP INC/RI
13F
Company
0.11%
33,606
$73,933 30 Jun 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.1%
32,472
$71,438 30 Jun 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.08%
26,477
$57,000 30 Jun 2025
13F
BROWN ADVISORY INC
13F
Company
0.08%
25,000
$55,000 30 Jun 2025
13F
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
13F
Company
0.07%
22,175
$48,785 30 Jun 2025
13F
Jain Global LLC
13F
Company
0.07%
21,171
$46,576 30 Jun 2025
13F
AlphaCore Capital LLC
13F
Company
0.06%
20,000
$44,000 30 Jun 2025
13F
Bowie Capital Management, LLC
13F
Company
0.06%
19,484
$42,865 30 Jun 2025
13F

Institutional Holders of Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO) as of Q3 2025

As of 30 Sep 2025, Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO) was held by 74 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,755,091 shares. The largest 10 holders included Alpha Wave Global, LP, ARMISTICE CAPITAL, LLC, Point72 Asset Management, L.P., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, Vestal Point Capital, LP, MARSHALL WACE, LLP, 72 Investment Holdings, LLC, ALKEON CAPITAL MANAGEMENT LLC, and NORTHERN TRUST CORP. This page lists 74 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
78
Q3 2025 holders
74
Holder diff
-4
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .